GlassScriptPhysician profile
Jude A Mugerwa
NPI 1639112642
$7,486.68
in general payments reported to CMS, 2019-2025
35 companies · $1,302 in 2025
The $1,302 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $798 · 2020: $291 · 2022: $1,612 · 2023: $1,525 · 2024: $1,958 · 2025: $1,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,685 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,685.07 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $965.24 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $771.12 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $665.54 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $617.72 | 2019-2025 | Jardiance |
| Amgen INC. | $585.24 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $478.72 | 2022-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $449.79 | 2020-2025 | |
| Pfizer INC. | $387.19 | 2019-2025 | |
| Irhythm Technologies, INC. | $323.54 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $263.06 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Boston Scientific Corporation | $222.81 | 2022-2025 | Watchman Flx, Watchman, Watchman Access System |
| Scpharmaceuticals INC. | $194.69 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $193.15 | 2019-2025 | Brilinta, Farxiga |
| Lexicon Pharmaceuticals, INC. | $175.97 | 2023-2024 | Inpefa |
| Abbott Laboratories | $154.05 | 2023-2024 | Accent, Cardiomems, Jot Dx |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $128.46 | 2019-2024 | Opsumit, Uptravi |
| Esperion Therapeutics, INC. | $119.83 | 2022-2025 | Nexletol |
| Medicomp INC | $97.81 | 2023-2025 | Telepatch Cardiac Monitor |
| Biotronik INC. | $89.30 | 2022-2025 | Biomonitor |
| Bridgebio Pharma, INC. | $71.02 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $70.67 | 2025 | Onpattro |
| Kowa Pharmaceuticals America, INC. | $67.26 | 2022 | |
| Sanofi-Aventis U.S. LLC | $66.63 | 2019-2020 | |
| Astellas Pharma US INC | $54.60 | 2022-2023 | Lexiscan |
| Gilead Sciences, INC. | $50.99 | 2019 | |
| Vifor Pharma, INC. | $41.01 | 2022 | |
| Atricure, INC. | $35.35 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $25.34 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.09 | 2025 | |
| Watermark Medical, INC. | $18.39 | 2025 | |
| Akcea Therapeutics, INC. | $17.96 | 2019 | |
| Siemens Medical Solutions USA, INC. | $17.71 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Tactile Systems Technology INC | $16.17 | 2022 | |
| Kestra Medical Technology Services, INC. | $15.97 | 2022 | |
| Amarin Pharma, INC. | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jude Mugerwa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.